You might like
Ready for Triathlon des Roses Toulouse. Notre équipe « l’Immunologie en Rose » a collecté 600 euros 🥳 @crctoncopole @IUCTOncopole @InfinityTLS @asdejean
🇬🇧@UT3PaulSabatier , in partnership with @crctoncopole , @CanceropoleGSO and @PierreFabre , offers an intensive short program on Oncology and Dermatology in Toulouse for summer 2024. ➡️canceropole-gso.org/?p=calendrier&…
🇫🇷@UT3PaulSabatier, en partenariat avec @crctoncopole, @CanceropoleGSO et @PierreFabre, propose un programme court intensif en oncologie et dermatologie à Toulouse pour l'été 2024. ➡️canceropole-gso.org/?p=calendrier&…
Melasphinx team is proud of Mathieu Virazels (PhD student) for his poster #eacrImmunoOncology #melanoma #Immunotherapy #tnf @crctoncopole @IUCTOncopole @melasphinx @CareGraduate
Very nice presentation by Bruno Ségui on #melanoma #eacrImmunoOncology , #immunecheckpoint inhibitors +/-#tnf inhibitors @crctoncopole @IUCTOncopole @melasphinx @CareGraduate
Doctoral Scholarships for Afghan women students offered by universities in #Toulouse @IpbsToulouse and @CbiToulouse willing to welcome a PhD candidate @UT3PaulSabatier Do not hesitate to contact us for information. DEADLINE FOR APPLICATION: NOV 15, 2021
[CRCT news] crct-inserm.fr/en/a-new-immun… @Melasphinx @Caregraduate ; @CCR_AACR @ToulouseCancer @FRM_officiel @BMSFrance @CanceropoleGSO #TNF, #antiTNF, #PD1, #CTLA4, #melanoma, #nivolumab, #ipilimumab, #infliximab, #certolizumab
crct-inserm.fr
A new immunotherapy strategy in melanoma patients. - Toulouse Cancer Research Center
Melanoma is a bad-prognosis skin cancer generally treated with monoclonal antibodies that neutralize immune checkpoints such as anti-CTLA-4 (ipilimumab) or anti-PD-1 (nivolumab). Unfortunately, a...
Bravo @BalancaCamille @ClaraScarlata @cmartgomez @DrGomezRoca et al. @crctoncopole @IUCTOncopoleICR @JCI_insight PD-1 blockade restores helper activity of tumor-infiltrating exhausted PD-1hiCD39+ CD4 T cells. insight.jci.org/articles/view/…
First clinical and biological data on Ticimel clinical trial in #melanoma patients treated with #ipilimumab, #nivolumab, #infliximab or #certolizumab.
Phase Ib clinical trial finds that #nivolumab and #ipilimumab combined with #infliximab or #certolizumab are safe and provide clinical and biological activities in patients with advanced or metastatic #Melanoma. Montfort et al @TeamT2i @melasphinx bit.ly/2W4RUcO
Blockade of #TNF, #PD-1 and #CTLA-4 in #melanoma patients: #CRCT #IUCT (Toulouse Oncopole, France) Combining #nivolumab and #ipilimumab with #infliximab or #certolizumab in patients with advanced melanoma: first results of a phase 1b clinical trial clincancerres.aacrjournals.org/content/early/…
See the new Comment from Schett et al. on COVID-19: risk for cytokine targeting in chronic inflammatory diseases? nature.com/articles/s4157…
Merci à tous les mobilisés & et aux acteurs qui permettent cette mobilisation massive 💪 Continuons de prendre soin les uns des autres & l'interpro pour flatten the curve 🔥 @JulieOudet @elus_rangueil @Pharma_ANEPF @UT3PaulSabatier @ARS_OC @CHUdeToulouse actu.fr/occitanie/toul…
We need more testing in France, now! My neighbour, a family doctor, said she saw 6 suspicious cases today and one of them pretty obvious left with an ambulance... please!
Les #etudiants en santé (#Pharmacie #dentaire #Medecine) volontaires de @UT3PaulSabatier sont formés par le #SAMU31 pour venir en aide aux #soignants et #patients du @CHUdeToulouse face au #Covid_19
Scientists say that the suggestion that pangolins are the animal source of the coronavirus outbreak seems plausible based on a genetic analysis, but they also caution that the researchers’ work is yet to be published in full. go.nature.com/2HfWLkh
Aujourd’hui : Double intervention a la 1ere Journée sur les Opportunités de Carrière a l’International après le Doctorat organisée par l’Université de Toulouse. Excellente initiative pour promouvoir l’internationalité des parcours académiques! @UT3PaulSabatier @Univ_Toulouse
You can also find out more about what Ton Schumacher and others think about T cell dysfunction in cancer and chronic infection in a recent Viewpoint by @NatRevImmunol 'Defining T cell exhaustion' go.nature.com/2vYsi7X
NEW Review by Ton N Schumacher et al, on #CD8T cell states that have been identified in human tumours using #singlecell #RNAseq, the potential roles they play in tumour control as well as how they are influenced by #ImmuneCheckpointBlockade. bit.ly/CD8T_TNS @NatResCancer
'Immune crosstalk in cancer progression and metastatic spread' A new #Review that highlights intriguing parallels between inflammatory disorders and cancer progression go.nature.com/2vTuWf1 by Hannah Garner and Karin de Visser @NKI_nl
Excellentes idées. Congrats et merci beaucoup aux étudiants!
Nos étudiants organisent 2 événements dans le cadre de la @TOW_2020 ! 😉 RDV ce dimanche à @Toulouse pour : 👉 Découvrir l'Onco Snow Village : bit.ly/2t7fxXk ❄ 👉 Participer à l'Onco Run : bit.ly/2S0rmad 🏃🏻♀️🏃🏾♂️ #TOW2020 @Liguevscancer31 #Toulouse
United States Trends
- 1. Tourette N/A
- 2. Pritchard N/A
- 3. Canada N/A
- 4. El Mencho N/A
- 5. Reddick N/A
- 6. Puerto Vallarta N/A
- 7. Hocevar N/A
- 8. Canadians N/A
- 9. México N/A
- 10. Pat Riley N/A
- 11. #NASCAR N/A
- 12. Celtics N/A
- 13. Jalisco N/A
- 14. CJNG N/A
- 15. Bubba N/A
- 16. Delroy N/A
- 17. #Autotrader400 N/A
- 18. Podz N/A
- 19. Olympics N/A
- 20. Kash Patel N/A
You might like
Something went wrong.
Something went wrong.